The need for global regulation of antibiotics: The case of a generic oral penem

Clinical Infectious Diseases

Volumn 62, Issue 11, 2016, Pages 1466-1467

  Tiberi, Simon ^a   Sanz, Marta G ^a   Millar, Michael ^a  

^a ROYAL LONDON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DORIPENEM; ERTAPENEM; FROPENEM; GENERIC DRUG; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; CARBAPENEM DERIVATIVE; THIENAMYCIN DERIVATIVE;

ANIMAL HUSBANDRY; ANTIBIOTIC RESISTANCE; CHINA; DRUG FORMULATION; DRUG USE; GOVERNMENT REGULATION; HUMAN; INDIA; INFECTION; LETTER; NONHUMAN; PRESCRIPTION; PRIORITY JOURNAL;

ANTI-BACTERIAL AGENTS; CARBAPENEMS; DRUGS, GENERIC; HUMANS; THIENAMYCINS;

EID: 84971524719     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw143     Document Type: Letter

References (5)

1. Gandra S, Klein EY, Pant S, Malhotra-Kumar S, Laxminarayan R. Faropenemconsumption is increasing in India. Clin Infect Dis 2016; 62:1050-2.
2. Gettig JP, Crank CW, Philbrick AH. Faropenem medoximil. Ann Pharmacother 2008; 42:80-90.
3. Nugent R, Okeke N. When medicines fail: recommendations for curbing antibiotic resistance. J Infect Dev Ctries 2010; 4:355-6.
4. European Surveillance of Antimicrobial Consumption. ESAC yearbook 2009, Antwerp, Belgium.
5. Ostrom E. Governing the commons: the evolution of institutions for collective action. New York, NY: Cambridge University Press, 1990.